Discovery of a ligand that compensates for decreased endogenous agonist potency of melanocortin-4 receptor polymorphisms identified in obese humans.

Carrie Haskell-Luevano, Zhimin Xiang, Andrzej M. Wilczynski, Kimberly R. Haskell, Amy M. Andreasen, Sally A. Litherland, William J. Millard, Ira D. Pogozheva, Henry I. Mosberg, Nicholas B. Sorenson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)509-510
Number of pages2
JournalAdvances in experimental medicine and biology
StatePublished - 2009

Bibliographical note

Funding Information:
This work has been supported by NIH Grants to CHL(DK063974, DK57080, DK64250) and to HIM (DA003910) and an ADA Research Award (CHL).

Cite this